AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties
暂无分享,去创建一个
Mark H. Norman | J. Treanor | T. Vanderah | J. Louis | F. Porreca | E. Doherty | A. Bannon | N. Gavva | M. Norman | Yusheng Qu | Frank Porreca | Jean-Claude Louis | Todd W. Vanderah | D. Immke | Yusheng Qu | Judy Wang | Narender R. Gavva | James J. S. Treanor | Dawn Zhu | Rami Tamir | Lana Klionsky | T. J. Zhang | David Immke | Elizabeth M. Doherty | Kenneth D. Wild | Anthony W. Bannon | K. Wild | L. Klionsky | Judy Wang | T. J. Zhang | R. Tamir | D. Zhu | M. H. Norman | Jean Claude Louis
[1] David Julius,et al. Molecular Basis for Species-Specific Sensitivity to “Hot” Chili Peppers , 2002, Cell.
[2] L. Petrocellis,et al. N-Oleoyldopamine, a Novel Endogenous Capsaicin-like Lipid That Produces Hyperalgesia* , 2003, The Journal of Biological Chemistry.
[3] B. Sakmann,et al. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.
[4] S. Bevan,et al. Pharmacological differences between the human and rat vanilloid receptor 1 (VR1) , 2001, British journal of pharmacology.
[5] H. Schild,et al. SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.
[6] R. Lindsay,et al. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[7] A. Szallasi,et al. Biochemical pharmacology of the vanilloid receptor TRPV1 , 2004 .
[8] Makoto Tominaga,et al. Acid potentiation of the capsaicin receptor determined by a key extracellular site , 2000 .
[9] Ji-Min Kim,et al. N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor. , 2003, Journal of medicinal chemistry.
[10] S. Hwang,et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] C. Foged,et al. Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. , 2001, Molecular pharmacology.
[12] S. Teague,et al. Functional Properties of the High-Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist (4-Hydroxy-5-iodo-3-methoxyphenylacetate ester) Iodo-Resiniferatoxin , 2002, Journal of Pharmacology and Experimental Therapeutics.
[13] J. Davies,et al. The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. , 1994, Journal of medicinal chemistry.
[14] S. Arneric,et al. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization. , 1998, The Journal of pharmacology and experimental therapeutics.
[15] P. McIntyre,et al. The VR1 Antagonist Capsazepine Reverses Mechanical Hyperalgesia in Models of Inflammatory and Neuropathic Pain , 2003, Journal of Pharmacology and Experimental Therapeutics.
[16] C. Davies,et al. Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist , 2004, Neuropharmacology.
[17] R. Jostock,et al. Characterization of the mouse cold‐menthol receptor TRPM8 and vanilloid receptor type‐1 VR1 using a fluorometric imaging plate reader (FLIPR) assay , 2004, British journal of pharmacology.
[18] D. Clapham,et al. The trp ion channel family , 2001, Nature Reviews Neuroscience.
[19] B. Bean,et al. Role of Tetrodotoxin-Resistant Na+ Current Slow Inactivation in Adaptation of Action Potential Firing in Small-Diameter Dorsal Root Ganglion Neurons , 2003, The Journal of Neuroscience.
[20] M. Iadarola,et al. Anandamide Activates Vanilloid Receptor 1 (VR1) at Acidic pH in Dorsal Root Ganglia Neurons and Cells Ectopically Expressing VR1* , 2001, The Journal of Biological Chemistry.
[21] G. Appendino,et al. Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists , 2003, British journal of pharmacology.
[22] A. Szallasi,et al. Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse? , 2004, Journal of medicinal chemistry.
[23] Attila Toth,et al. Molecular Determinants of Vanilloid Sensitivity in TRPV1* , 2004, Journal of Biological Chemistry.
[24] P. Blumberg,et al. 3-Acyloxy-2-phenalkylpropyl amides and esters of homovanillic acid as novel vanilloid receptor agonists. , 1999, Bioorganic & medicinal chemistry letters.
[25] D. Julius,et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.
[26] C. Créminon,et al. Anandamide Excites Central Terminals of Dorsal Root Ganglion Neurons via Vanilloid Receptor-1 Activation , 2001, The Journal of Neuroscience.
[27] L. Premkumar,et al. Induction of vanilloid receptor channel activity by protein kinase C , 2000, Nature.
[28] S. Bingham,et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia , 2000, Nature.
[29] R. Dubner,et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.
[30] R. Gracely,et al. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects , 1995, PAIN®.
[31] A I Basbaum,et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. , 2000, Science.
[32] P. Reeh,et al. Rat peripheral nerve components release calcitonin gene-related peptide and prostaglandin E2 in response to noxious stimuli: evidence that nervi nervorum are nociceptors * S. K. Sauer and G. M. Bove contributed equally to this study. * , 1999, Neuroscience.
[33] J. Pomonis,et al. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain , 2003, Journal of Pharmacology and Experimental Therapeutics.
[34] Peter McIntyre,et al. Identification of Species-specific Determinants of the Action of the Antagonist Capsazepine and the Agonist PPAHV on TRPV1* , 2004, Journal of Biological Chemistry.
[35] C. Woolf,et al. p38 MAPK Activation by NGF in Primary Sensory Neurons after Inflammation Increases TRPV1 Levels and Maintains Heat Hyperalgesia , 2002, Neuron.
[36] Qun Sun,et al. N-(4-Tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: I. In Vitro Characterization and Pharmacokinetic Properties , 2003, Journal of Pharmacology and Experimental Therapeutics.
[37] Pierangelo Geppetti,et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[38] P. McIntyre,et al. Cloning and functional characterization of the guinea pig vanilloid receptor 1 , 2002, Neuropharmacology.
[39] N. Chen,et al. Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides. , 2005, Journal of medicinal chemistry.